From: Clinical significance of urinary inflammatory biomarkers in patients with IgA nephropathy
 | IgAN (n = 191) | Disease control (n = 53) | Normal control (n = 76) | Pd |
---|---|---|---|---|
Age, years | 41.3 ± 15.3 | 46.4 ± 17.7b | 38.4 ± 15.4 | 0.018 |
Male, n (%) | 99 (51.8)a | 33 (62.3)b | 19 (25.0)c | < 0.0001 |
HTN, n (%) | 80 (41.9) | 20 (37.7) | 0 (0.0)c | < 0.0001 |
DM, n (%) | 10 (5.2)a | 10 (18.9)b | 0 (0.0)c | < 0.0001 |
BMI, kg/m2 | 23.9 ± 3.3 | 24.8 ± 3.2 | 22.9 ± 3.5c | 0.005 |
Albumin, g/dL | 3.9 ± 0.6a | 2.9 ± 0.9b | 4.5 ± 0.2c | < 0.0001 |
Creatinine, mg/dL | 1.2 ± 0.9a | 0.9 ± 0.6b | 0.7 ± 0.1c | < 0.0001 |
eGFR, ml/min/1.73 m2 | 83.0 ± 34.5a | 96.7 ± 33.6b | 109.6 ± 15.6c | < 0.0001 |
C3, mg/dL | 108.9 ± 20.7 | 116.6 ± 20.5 | N/A | 0.015 |
IgA, mg/dL | 305.5 ± 103.9 | 242.5 ± 87.4 | N/A | < 0.0001 |
Urine PCR, g/gCr | 1.7 ± 2.1a | 5.4 ± 5.6b | 0.1 ± 0.1c | < 0.0001 |